The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 29, 2013
Filed:
Jun. 18, 2012
Roy A. Jensen, Gardner, KS (US);
Lisa M. Harlan-williams, Lenexa, KS (US);
Frank J. Schoenen, Lawrence, KS (US);
Jeffrey Aube, Lawrence, KS (US);
Gerald H. Lushington, Lawrence, KS (US);
Roy A. Jensen, Gardner, KS (US);
Lisa M. Harlan-Williams, Lenexa, KS (US);
Frank J. Schoenen, Lawrence, KS (US);
Jeffrey Aube, Lawrence, KS (US);
Gerald H. Lushington, Lawrence, KS (US);
University of Kansas, Lawrence, KS (US);
Abstract
A pharmaceutical composition for use in treating, inhibiting, and/or preventing breast and/or ovarian cancer can include: a molecule having a structure of one of Compounds 1-38, pharmaceutically acceptable salt thereof, or analog thereof; and a pharmaceutically acceptable carrier containing the compound. The pharmaceutically acceptable carrier can be configured for oral, systemic, transdermal, intranasal, suppository, parenteral, intramuscular, intravenous, or subcutaneous administration. The compound can be present in the composition in a therapeutically effective amount for treating, inhibiting, and/or preventing breast and/or ovarian cancer. Also, the compound can be present in a therapeutically effective amount for enhancing production of BRCA1.